Patents by Inventor Friedrich-Robert Seiler

Friedrich-Robert Seiler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for detecting and determining mediators
    Patent number: 6475717
    Abstract: The invention relates to a method for detecting and determining mediators and/or their derivatives in fluids, the mediator being detected directly or indirectly with the aid of a recombinant, soluble receptor for the mediator to be detected.
    Type: Grant
    Filed: July 25, 1997
    Date of Patent: November 5, 2002
    Assignee: Dade Behring Marburg GmbH
    Inventors: Karlheinz Enssle, Roland Kurrle, Klaus-Dieter Langner, Leander Lauffer, Josef-Urban Pauly, Friedrich-Robert Seiler
  • Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections
    Patent number: 6328954
    Abstract: The use of the IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections. The invention relates to the use of the IL-4 receptor or of derivatives thereof for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: December 11, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Karlheinz Enssle, Roland Kurrle, Leander Lauffer, Friedrich-Robert Seiler
  • IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections
    Patent number: 6210661
    Abstract: The IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections. The invention relates to the il-4 receptor or variants thereof for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: April 3, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Karlheinz Enssle, Roland Kurrle, Leander Lauffer, Friedrich-Robert Seiler
  • Magnetic protein conjugates, a process for the preparation thereof, and the use thereof
    Patent number: 5672687
    Abstract: The invention relates to magnetic protein conjugates of the formula I ##STR1## in which M represents a dispersible magnetically reacting material or particle which carries aminogroups, Ig represents a protein which carries one or more mercapto groups, and X represents an organic chemical structure which links the two ligands by chemical means, to a process for the preparation of protein conjugates of the formula I, and to the use of conjugates of this type for removing cells or soluble bioorganic molecules or components from aqueous salt solutions or body fluids, and to the use thereof within the framework of a diagnostic method or as a diagnostic aid.
    Type: Grant
    Filed: January 19, 1995
    Date of Patent: September 30, 1997
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Peter Hermentin, Reiner Donges, Karlheinz Enssle, Roland Kurrle, Friedrich Robert Seiler
  • Composition containing the P40 subunit of interleukin-12
    Patent number: 5547852
    Abstract: The present invention relates to a composition containing the p40 subunit of interleukin-12, hereinafter referred to as p40/IL-12 and to methods of diagnosis and treatment of disorders associated with disregulation of the immune system.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: August 20, 1996
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Friedrich-Robert Seiler, Roland Kurrle, Klaus-Dieter Langner
  • Immunologic determination method
    Patent number: 4166106
    Abstract: A method for determininng a reagent capable of immunologic reaction by direct or indirect test methods, wherein an antigen is contacted with the Fc fragment of an immune globulin prior to contacting it with an antibody having no specificity to said Fc fragment, whereby unspecific linkages arre decreased.
    Type: Grant
    Filed: September 22, 1977
    Date of Patent: August 28, 1979
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Hans-Harald Sedlacek, Roloff Johannsen, Friedrich-Robert Seiler